6/11/2013

Endo Health Solutions announced plans to reduce its worldwide workforce by 15%, about 700 jobs, and possibly sell its HealthTronics urological products and services business. Impax reduced its workforce by about 10%, or 110 jobs, and Zogenix announced 55 job cuts, or 37% of its workforce.

Full Story:
PharmaTimes (U.K.)

Related Summaries